There was a time when buying medicine wasn’t a frantic, app-based, 10-minute affair. It was a ritual—a visit to the trusted neighbourhood chemist, a quick chat about the latest cricket match, and a reassuring nod as they handed over your prescription. If you were lucky, they even threw in a lozenge for free. Fast forward to today, and buying medicines has gone from ‘Bhaiya, yeh wala syrup hai?’ to ‘Ding dong! Your meds are here With Swiggy, Blinkit, and Zepto now gunning for a piece of the pharma pie, the rules of the game are changing—fast. PharmEasy has already teamed up with Swiggy in Bengaluru, Apollo 24/7 is racing against time with 30-minute medicine deliveries, and Tata 1mg is eyeing a partnership with BigBasket. But here’s the real question—does this mean an investment jackpot in healthcare and quick commerce stocks, or are we looking at a regulatory nightmare waiting to unfold? Read on: https://www.kotaksecurities.com/investing-guide/articles/quick-commerce-meets-healthcare?utm_source=social&utm_medium=wa&utm_campaign=kotak-insights